IMDX

Insight Molecular Diagnostics Inc. Common Stock

7.40

USD

IMDX Earnings Reports

Positive Surprise Ratio

IMDX beat 15 of 40 last estimates.

38%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$295.80K

-$0.24

Implied change from Q3 25 (Revenue/ EPS)

+13.77%

-29.41%

Implied change from Q4 24 (Revenue/ EPS)

-80.09%

-87.56%

Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, IMDX reported earnings of -0.34 USD per share (EPS) for Q3 25, missing the estimate of -0.21 USD, resulting in a -58.95% surprise. Revenue reached 260.00 thousand, compared to an expected 289.68 thousand, with a -10.25% difference. The market reacted with a +10.66% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 295.80 thousand USD, implying an decrease of -29.41% EPS, and increase of 13.77% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Azenta, Inc.

Report Date

Feb 04, 2026 For Q1 26

Estimate

$0.14

Actual

$0.09

Surprise

-35.94%

Doximity, Inc.

Report Date

Feb 05, 2026 For Q3 26

Estimate

$0.45

Actual

$0.46

Surprise

+1.21%

Omnicell Inc

Report Date

Feb 05, 2026 For Q4 25

Estimate

$0.50

Actual

$0.40

Surprise

-20.98%

FAQ

What were Insight Molecular Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Insight Molecular Diagnostics Inc. Common Stock reported EPS of -$0.34, missing estimates by -58.95%, and revenue of $260.00K, -10.25% below expectations.

How did the market react to Insight Molecular Diagnostics Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 10.66%, changed from $6.80 before the earnings release to $7.53 the day after.

When is Insight Molecular Diagnostics Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Insight Molecular Diagnostics Inc. Common Stock's next earnings report?

Based on 6 analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $295.80K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.